MOLN
Molecular Partners AG ADRNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$139.17M
P/E Ratio
—
EPS
$-1.95
Beta
0.71
52W High
$5.36
52W Low
$3.41
50-Day MA
$4.10
200-Day MA
$4.16
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
1.70
PEG Ratio
—
About Molecular Partners AG ADR
Molecular Partners AG is a clinical-stage biopharmaceutical company. The company is headquartered in Schlieren, Switzerland.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-36.66M |
| EBITDA | $-51.89M |
| Operating Margin | 0.00% |
| Return on Equity | -59.00% |
| Return on Assets | -28.80% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.33 |
| Price-to-Book | 1.62 |
| Price-to-Sales (TTM) | 156.56 |
| EV/Revenue | 3.814 |
| EV/EBITDA | 1.24 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $37.51M |
| Float | $19.92M |
| % Insiders | 0.00% |
| % Institutions | 9.58% |
Historical Volatility
HV 10-Day
76.56%
HV 20-Day
67.01%
HV 30-Day
59.82%
HV 60-Day
55.65%
HV Rank
60.7%
Volatility is currently expanding
Analyst Ratings
Consensus ($10.97 target)
4
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026